Pterygium
Conditions
Brief summary
To evaluate changes in endothelial cell count after pterygium surgery with mitomycin C (MMC) 0.02%
Detailed description
To evaluate the change in endothelial cell count in patients after pterygium surgery with mitomycin C (MMC) 0.02% for 2 minutes in 2 groups. * The control group: application of MMC after excision of the body of the pterygium without the head * The study group: application of MMC after excision of the body and the head of the pterygium
Interventions
Pterygium excision with application of mitomycin C
PROCEDUREPterygium surgery
Two different procedures- excision of the head and the body and excision of the head only
Sponsors
Meir Medical Center
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Males/females \>18 Years old * Pterygium with indication to operate * Subjects that are able to sign an informed consent
Exclusion criteria
* Recurrent Pterygium/suspected tumor lesion * Patients with endothelial cell diseases * Patients after anterior segment surgery * Patients with low compliance * Patients without judgment ability * Pregnancy * Patients participated in another survey
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Endothelial cell count | 3 months after surgery |
Countries
Israel
Contacts
Primary ContactFani Segev, MD
Backup ContactLeena Asalee, MD
Outcome results
None listed